Status:
COMPLETED
Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
COVID
Eligibility:
All Genders
18+ years
Brief Summary
A new Coronavirus (SARS-CoV-2) emerged in Wuhan Province, China in December 2019 and rapidly spread around the world. To date, the data in the literature regarding the clinical and epidemiological cha...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years of age
- Diagnosis of CoVid-2 SARS infection retained (from clinical presentation, radiological and CoVid-19 positive microbiological specimen).
- Hospitalisation in the conventional medical sector for "respiratory" reasons (= severe form of CoVid-19) in the Nancy-Brabois hospital and Metz-Thionville Hospital between 02/03/2020 and 15/06/2020.
Exclusion
- Diagnosis of SARS-CoV-2 infection not retained
- Refusal of the patient to participate in the study
- Persons referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code: o Pregnant woman, parturient or breastfeeding mother o Minors (not emancipated) o Persons of full age subject to a legal protection measure (guardianship, curatorship, safeguard of justice) - Persons of full age unable to express their consent Persons deprived of their liberty by a judicial or administrative decision, persons subject to psychiatric care by virtue of articles L. 3212-1 and L. 3213-1.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 17 2020
Estimated Enrollment :
617 Patients enrolled
Trial Details
Trial ID
NCT04407169
Start Date
June 1 2020
End Date
November 17 2020
Last Update
November 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Valentin Simon
Vandœuvre-lès-Nancy, France, 54500